Cantor Fitzgerald analyst reiterated an Overweight rating on Glycomimetics (NASDAQ: GLYC).The analyst commented, “Crescent is reverse-merging into GlycoMimetics (ticker GLYC) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE